AHR and neoplasm: IL4I1 is associated more frequently than IDO1 or TDO2 with the activity of aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor that can sense tryptophan (Trp) catabolites, enhancing tumor malignancy and suppressing antitumor immunity [227–229].